Recombinant DMA Advisory Committee - 21^191 
XII. ADJOURNMENT: 
Having concluded the agenda and there being no further business to be discussed, Dr. 
McGarrity adjourned the committee at 3:55 p.m., on February 4, 1991. 
Kelson A. Wivel, M.D. 
Executive Secretary 
I hereby acknowledge that, to the best of my 
knowledge, the foregoing Minutes and 
Attachments are accurate and complete. 
Kecomomant uin/v Aovisory L;ommittee 
National Institutes of Health 
Date: mi 
[492] 
Recombinant DNA Research, Volume 14 
